These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 17419138

  • 21. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
    Tyring SK, Douglas JM, Corey L, Spruance SL, Esmann J.
    Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
    [Abstract] [Full Text] [Related]

  • 22. Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial.
    Tan DH, Raboud JM, Kaul R, Grinsztejn B, Cahn P, Walmsley SL.
    Trials; 2010 Nov 24; 11():113. PubMed ID: 21106086
    [Abstract] [Full Text] [Related]

  • 23. Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2.
    Roxby AC, Drake AL, Ongecha-Owuor F, Kiarie JN, Richardson B, Matemo DN, Overbaugh J, Emery S, John-Stewart GC, Wald A, Farquhar C.
    PLoS One; 2012 Nov 24; 7(6):e38622. PubMed ID: 22701683
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Successors to acyclovir.
    Easterbrook P, Wood MJ.
    J Antimicrob Chemother; 1994 Sep 24; 34(3):307-11. PubMed ID: 7829405
    [No Abstract] [Full Text] [Related]

  • 28. Famciclovir or valaciclovir in the management of herpes simplex and varicella zoster infections: an attitudinal survey of clinician perceptions of differential activity.
    Smith DE, Gold J.
    Sex Health; 2007 Jun 24; 4(2):141-2. PubMed ID: 17524295
    [No Abstract] [Full Text] [Related]

  • 29. Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients.
    Warkentin DI, Epstein JB, Campbell LM, Yip JG, Cox VC, Ransier A, Barnett MJ, Marra F.
    Ann Pharmacother; 2002 Oct 24; 36(10):1525-31. PubMed ID: 12243600
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial.
    Aurelius E, Franzen-Röhl E, Glimåker M, Akre O, Grillner L, Jorup-Rönström C, Studahl M, HSV-2 Meningitis Study Group.
    Clin Infect Dis; 2012 May 24; 54(9):1304-13. PubMed ID: 22460966
    [Abstract] [Full Text] [Related]

  • 32. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
    DeJesus E, Wald A, Warren T, Schacker TW, Trottier S, Shahmanesh M, Hill JL, Brennan CA, Valacyclovir International HSV Study Group.
    J Infect Dis; 2003 Oct 01; 188(7):1009-16. PubMed ID: 14513421
    [Abstract] [Full Text] [Related]

  • 33. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
    Yi TJ, Walmsley S, Szadkowski L, Raboud J, Rajwans N, Shannon B, Kumar S, Kain KC, Kaul R, Tan DH.
    Clin Infect Dis; 2013 Nov 01; 57(9):1331-8. PubMed ID: 23946220
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cutaneous HSV-2 infection with serial recurrences at multiple sites.
    Dacko A, Don PC, Weinberg JM.
    Int J Dermatol; 2002 Feb 01; 41(2):109-11. PubMed ID: 11982649
    [No Abstract] [Full Text] [Related]

  • 36. Successful treatment of generalized primary herpes simplex type 2 infection during pregnancy.
    Anderson R, Lundqvist A, Bergström T.
    Scand J Infect Dis; 1999 Feb 01; 31(2):201-2. PubMed ID: 10447333
    [Abstract] [Full Text] [Related]

  • 37. HIV and STDs--oral manifestations.
    Hammond L.
    Aust Fam Physician; 1997 Nov 01; 26(11):1346-7. PubMed ID: 9386323
    [No Abstract] [Full Text] [Related]

  • 38. Methylprednisolone, valacyclovir, or both for vestibular neuritis.
    Tenser RB.
    N Engl J Med; 2004 Nov 25; 351(22):2344-5; author reply 2344-5. PubMed ID: 15570683
    [No Abstract] [Full Text] [Related]

  • 39. Herpes Simplex Virus Suppressive Therapy in Herpes Simplex Virus-2/Human Immunodeficiency Virus-1 Coinfected Women Is Associated With Reduced Systemic CXCL10 But Not Genital Cytokines.
    Andersen-Nissen E, Chang JT, Thomas KK, Adams D, Celum C, Sanchez J, Coombs RW, McElrath MJ, Baeten JM.
    Sex Transm Dis; 2016 Dec 25; 43(12):761-764. PubMed ID: 27832025
    [Abstract] [Full Text] [Related]

  • 40. Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients.
    Liesveld JL, Abboud CN, Ifthikharuddin JJ, Lancet JE, Wedow LA, Oliva J, Stamm CG, Nichols D.
    Biol Blood Marrow Transplant; 2002 Dec 25; 8(12):662-5. PubMed ID: 12523578
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.